Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
Tetrapropylammonium → 1-(3-Isopropyl-1,2,4-oxadiazol-5-YL)piperidin-4-one
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|---|---|---|
| 반응물 | Tetrapropylammonium | HCID 9559 | — |
| 반응물 | Methyl morpholine oxide | HCID 82029 | — |
| 반응물 | 1-(3-Isopropyl-1,2,4-oxadiazol-5-YL)piperidin-4-OL | HCID 21897744 | — |
| 용매 | Dichloromethane | HCID 6344 | — |
| 생성물 | 1-(3-Isopropyl-1,2,4-oxadiazol-5-YL)piperidin-4-one | HCID 66915348 | — |
반응 단계
1-[3-(Propan-2-yl)-1,2,4-oxadiazol-5-yl]piperidin-4-ol (0.5 g) is dissolved in dichloromethane (75 mL) and 4 A molecular sieves (4 g) is added followed by N-methylmorpholine-N-oxide (1.52 g) and tetrapropylammonium perrhutenate (0.018 g) and the mixture is stirred at room temperature for 1 h. The reaction is filtered through celite and the filtrate is washed with water (2×50 mL). The combined aqueous layers are extracted with dichloromethane (100 mL). The organic layers are combined, dried over Na2SO4, filtered and concentrated to a dark liquid which crystallized upon standing to yield the title compound.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 특허 번호 | US08822471B2 |
| 출처 데이터셋 | uspto-grants-2014_09 |
| ORD ID | ord-14b90347dac24a2196daa5dccd2838e0 |
| 출처 메모 | uspto-grants-2014_09 |